These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32132314)

  • 41. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F; Yukawa E; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study.
    Pastori D; Carnevale R; Nocella C; Bartimoccia S; Novo M; Cammisotto V; Piconese S; Santulli M; Vasaturo F; Violi F; Pignatelli P;
    J Am Heart Assoc; 2018 Nov; 7(22):e009509. PubMed ID: 30571484
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Digoxin therapeutic drug monitoring: an audit and review.
    Sidwell A; Barclay M; Begg E; Moore G
    N Z Med J; 2003 Dec; 116(1187):U708. PubMed ID: 14752536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study.
    Oncu S; Baskurt A; Senturk B; Aslan O; Kume T; Ucku R; Gelal A
    Eur J Hosp Pharm; 2021 Nov; 28(6):320-324. PubMed ID: 34697048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring serum digoxin concentrations during digoxin immune Fab therapy.
    Ujhelyi MR; Colucci RD; Cummings DM; Green PJ; Robert S; Vlasses PH; Zarowitz BJ
    DICP; 1991 Oct; 25(10):1047-9. PubMed ID: 1803787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Digoxin plasma levels in four different prescription schedules of common use in clinical practice].
    Reinbach R; Villa L; Giraudo P; Venegas R; Fernández P
    Rev Med Chil; 2003 Apr; 131(4):373-80. PubMed ID: 12870231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monitoring digoxin serum concentrations: new thoughts concerning an old drug.
    Farver D
    S D J Med; 1999 May; 52(5):161-2. PubMed ID: 10358445
    [No Abstract]   [Full Text] [Related]  

  • 49. Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range.
    Morris RG; Jones TE; Goldsworthy SJ; Wagner TJ; Ho H; Horowitz JD
    Ther Drug Monit; 2006 Jun; 28(3):454-7. PubMed ID: 16778733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verapamil-digoxin interaction in chronic hemodialysis patients.
    Rendtorff C; Johannessen AC; Halck S; Klitgaard NA
    Scand J Urol Nephrol; 1990; 24(2):137-9. PubMed ID: 2356453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and predictors of digoxin utilization among heart failure patients with reduced ejection fraction in Qatar.
    Rahhal AA; Awaisu A; Tawengi KM; AbuYousef S; Mekideche L
    Int J Clin Pharm; 2017 Oct; 39(5):1070-1083. PubMed ID: 28823072
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case series of hospitalized patients with elevated digoxin levels.
    Marik PE; Fromm L
    Am J Med; 1998 Aug; 105(2):110-5. PubMed ID: 9727817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E; Suematu F; Yukawa M; Minemoto M; Ohdo S; Higuchi S; Goto Y; Aoyama T
    Clin Pharmacokinet; 2001; 40(10):773-81. PubMed ID: 11707062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of needs for therapeutic monitoring of digoxin in a tertiary hospital.
    Penkauskaite J; Maciulaitis R; Varanaviciene B; Milvidaite I; Tarutiene B
    Medicina (Kaunas); 2009; 45(1):46-50. PubMed ID: 19223705
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance.
    Konishi H; Shimizu S; Chiba M; Minouchi T; Koida M; Yamaji A
    J Clin Pharm Ther; 2002 Aug; 27(4):257-65. PubMed ID: 12174027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of clinical pharmacy services on appropriateness of serum digoxin concentration monitoring.
    Klamerus KJ; Munger MA
    Am J Hosp Pharm; 1988 Sep; 45(9):1887-93. PubMed ID: 3228120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic digoxin level in chylous drainage with no detectable plasma digoxin level.
    Taylor MD; Kim SS; Vaias LJ
    Chest; 1998 Nov; 114(5):1482-4. PubMed ID: 9824036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of coadministration of verapamil and quinidine on serum digoxin concentration.
    Doering W
    Eur J Clin Pharmacol; 1983; 25(4):517-21. PubMed ID: 6653647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal digoxin concentrations for patients with heart failure.
    Carbonin P; Zuccalà G
    JAMA; 2003 May; 289(20):2643; author reply 2643-4. PubMed ID: 12771104
    [No Abstract]   [Full Text] [Related]  

  • 60. Determination of digoxin serum level in patients with heart failure.
    Li Q; Wu G; Lu P
    Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):102-104. PubMed ID: 36800827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.